Viruses and interferon: a fight for supremacy
The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Abstract
The action of interferons (IFNs) on virus-infected cells and surrounding tissues elicits an antiviral state that is characterized by the expression and antiviral activity of IFN-stimulated genes. In turn, viruses encode mechanisms to counteract the host response and support efficient viral replication, thereby minimizing the therapeutic antiviral power of IFNs. In this review, we discuss the interplay between the IFN system and four medically important and challenging viruses -- influenza, hepatitis C, herpes simplex and vaccinia -- to highlight the diversity of viral strategies. Understanding the complex network of cellular antiviral processes and virus-host interactions should aid in identifying new and common targets for the therapeutic intervention of virus infection. This effort must take advantage of the recent developments in functional genomics, bioinformatics and other emerging technologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A pivotal study in 1987 reported that a subpopulation of people with viral hepatitis treated with interferon (IFN) α — a pro-inflammatory anti-viral cytokine13 — developed depression14, demonstrating that a pro-inflammatory molecule in the periphery could directly influence mood.”
From Central regulation of stress-evoked peripheral immune responses (2023) · cites this paper as [13]
In the citing paper
“The ISG expression of all monocytes combined and all macrophages combined was higher in HCV infection compared with NS–SS and MASH (Extended Data Fig. 4e), consistent with the role of ISGs as antiviral effectors11.”
In the citing paper
“Neutrophil recruitment is induced mainly by epithelium-derived IL-8/CXCL8, Gro-α/CXCL1, and ENA-78/CXCL5 (142, 178, 223).”
From The airway epithelium: soldier in the fight against respiratory viruses (2011) · cites this paper as [142]
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae
Uetz, P., Giot, L., Cagney, G., Mansfield, T. A., Judson, R. S., Knight, J. R., Lockshon, D., Narayan, V., Srinivasan, M., Pochart, P., et al. (2000) · Nature · doi:10.1038/35001009 · Cited by 4,706 · cited 1×
“, and to characterize global protein–protein interaction networks in an organis”
BackgroundVirus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Toll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
Antiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743 · cited 1×
“gif" NDATA ITEM> ]> Interferons (IFNs), although best known for their antiviral propertie”
Integrated Genomic and Proteomic Analyses of a Systematically Perturbed Metabolic Network
Ideker, T., Thorsson, V., Ranish, J. A., Christmas, R., Buhler, J., Eng, J. K., Bumgarner, R., Goodlett, D. R., Aebersold, R., & Hood, L. (2001) · Science · doi:10.1126/science.292.5518.929 · Cited by 2,050 · cited 1×
“This confluence of genomic and information technologies brings a powerful new approach to the study of biological systems, as exemplified by recent studie”
BackgroundDer, S. D., Zhou, A., Williams, B. R. G., & Silverman, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15623 · Cited by 1,816
A N EW A PPROACH TO D ECODING L IFE : Systems Biology
Ideker, T., Galitski, T., & Hood, L. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.343 · Cited by 1,664 · cited 1×
“Together, these technologies provide a global perspective on the complex interactions that occur between all levels of biological information ('systems biology'), from gene expression to protein productio”
Background
Research works printed but not linked: 7
- Biron, C. A. & Sen, G. C. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 321–352 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Witherell, G. W. & Beineke, P. Statistical analysis of combined substitutions in nonstructural 5A region of hepatitis C virus and interferon response. J. Med. Virol. 63, 8–16 (2001). · doi:10.1002/1096-9071(200101)63:1<8::aid-jmv1001>3.0.co;2-k
- Sumpter, R. Jr & Gale, M. Jr. in American Society for Virology 21st Annual Meeting W33-3 (Lexington, Kentucky, 2002).
- Whitley, R. J. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2461–2509 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Roizman, B. & Knipe, D. M. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2399–2460 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Esposito, J. J. & Fenner, F. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2849–2884 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Moss, B. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2885–2922 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
Cited by
Items 601–700 of 1,000
Novel strategies to eliminate persistent viral infections
Martinic, M. M. A., & von Herrath, M. G. (2008) · Trends in Immunology · doi:10.1016/j.it.2007.12.002 · Cited by 32
Rhesus Cytomegalovirus Particles Prevent Activation of Interferon Regulatory Factor 3
DeFilippis, V. R., & Früh, K. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.6419-6431.2005 · Cited by 35
“However, many of the endpoint genes induced in the IFN pathway are clearly detrimental to viral replication since they interfere with general protein translation or transport (20).”
BackgroundICP0 Prevents RNase L-Independent rRNA Cleavage in Herpes Simplex Virus Type 1-Infected Cells
Sobol, P. T., & Mossman, K. L. (2005) · Journal of Virology · doi:10.1128/jvi.80.1.218-225.2006 · Cited by 33
Free ISG15 inhibits Pseudorabies virus infection by positively regulating type I IFN signaling
Liu, H., Li, C., He, W., Chen, J., Yang, G., Chen, L., & Chang, H. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010921 · Cited by 35
“ISGF3 shuttles to the nucleus, where it binds to the IFN-stimulated response element (ISRE) in DNA and stimulates the transcription of hundreds of interferon-stimulated genes (ISGs) involved in antiviral immune responses [10,11].”
BackgroundCrosstalk between innate and adaptive immunity in hepatitis B virus infection
Wang, L., Wang, K., & Zou, Z.-Q. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i30.2980 · Cited by 34
How the Respiratory Epithelium Senses and Reacts to Influenza Virus
Benam, K. H., Denney, L., & Ho, L. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0247tr · Cited by 34
“Type II IFN, IFNγ is secreted by specific immune cell populations including CD8+ T cells, CD4+ T helper 1 (Th1) (93), invariant natural killer T (iNKT) (94), type 1 innate lymphoid cells (ILC1) (95) and NK cells (96).”
BackgroundInhibition of cGAS-Mediated Interferon Response Facilitates Transgene Expression
Fu, Y., Fang, Y., Lin, Z., Yang, L., Zheng, L., Hu, H., Yu, T., Huang, B., Chen, S., Wang, H., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101026 · Cited by 33
Cytokines profile in patients with acute and chronic hepatitis B infection
Ribeiro, C. R. D. A., Beghini, D. G., Salvio, A. L., Martinelli, K. G., Mello, V. M., de Almeida, N. A. A., Lewis‐Ximenez, L. L., & de Paula, V. S. (2021) · Microbiology and Immunology · doi:10.1111/1348-0421.12947 · Cited by 34
“Several viruses have developed strategies to avoid the IFN‐I response, inhibiting its production or its downstream effects.(37) IL‐10 can inhibit specific T‐cell responses, either directly or via effects on dendritic cells.”
BackgroundThe Innate Antiviral Response: New Insights Into A Continuing Story
Paun, A., & Pitha, P. M. (2006) · Advances in virus research · doi:10.1016/s0065-3527(06)69001-5 · Cited by 34
“All IRFs share significant homology in the N-terminal 115 amino acids, which comprises the DNA-binding domain, characterized by five tryptophan repeats.”
BackgroundInfluentialDeregulation of Interferon Signaling in Malignant Cells
Katsoulidis, E., Kaur, S., & Platanias, L. C. (2010) · Pharmaceuticals · doi:10.3390/ph3020406 · Cited by 41
“Extensive studies over the years have shown that IFNs are pleiotropic cytokines secreted by several cell types as part of the innate immune response [2–5].”
BackgroundSever, L., Vo, N. T. K., Bols, N. C., & Dixon, B. (2013) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2013.11.019 · Cited by 31
Lentiviral Vector-Mediated RNA Silencing in the Central Nervous System
Hutson, T. H., Foster, E., Moon, L. D. F., & Yáñez‐Muñoz, R. J. (2013) · Human Gene Therapy Methods · doi:10.1089/hgtb.2013.016 · Cited by 35
“TLRs are activated in response to microbial byproducts such as lipopolysaccharide (Katze et al., 2002); however, a number of subtypes, including TLR3, TLR7, and TRL8, have also been implicated in recognizing bacterial and viral nucleic acids (Alexopoulou et al.”
InfluentialLandolt, G. A., Townsend, H. G. G., & Lunn, D. P. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0891-8.00013-0 · Cited by 34
Ahmed, C. M. I., Burkhart, M. A., Subramaniam, P. S., Mujtaba, M. G., & Johnson, H. M. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5632-5639.2005 · Cited by 31
“(15), and yet IFN is the only therapy available to date to treat”
BackgroundChanges of HCV quasispecies during combination therapy with interferon and ribavirin
Ueda, E. (2004) · Hepatology Research · doi:10.1016/j.hepres.2004.02.014 · Cited by 30
Loving, C. L., Brockmeier, S. L., Ma, W., Richt, J. A., & Sacco, R. E. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8432 · Cited by 36
“Once phosphorylated, STAT1 can form a homodimer or a heterodimer with STAT2 (30) and bind to specific DNA promoter sequences to induce the transcription of various IFN-dependent genes (29).”
BackgroundZhao, S., Chang, X., Li, J., Yanhua, Z., Pan, X., Hua, Z., & Li, J. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.132554 · Cited by 30
Mosquito-borne flaviviruses and type I interferon: catch me if you can!
Zoladek, J., & Nisole, S. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1257024 · Cited by 36
“In this context, flaviviruses master the art and manner of inhibiting every single step of the innate immune response, in order to delay, if not prevent, the establishment of an antiviral response (Katze et al., 2002).”
BackgroundLiu, X., Chen, H., Ye, G., Liu, H., Feng, C., Chen, W., Hu, L., Zhou, Q., Zhang, Z., Li, J., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012136 · Cited by 35
“These ISGs maintain a potent antiviral response in ASFV-infected cells [10,11].”
BackgroundActivity-based protein profiling of host–virus interactions
Blais, D. R., Nasheri, N., McKay, C. S., Legault, M. C. B., & Pezacki, J. P. (2011) · Trends in biotechnology · doi:10.1016/j.tibtech.2011.08.001 · Cited by 30
Tsimis, M. E., Lei, J., Rosenzweig, J. M., Arif, H., Shabi, Y., Alshehri, W., Talbot, C., Baig-Ward, K. M., Segars, J. H., Graham, E. M., et al. (2017) · Biology of Reproduction · doi:10.1093/biolre/iox081 · Cited by 31
“Interferon γ has also been shown to induce Type 1 helper T cell to B cells, promoting proliferation and maturation [62].”
BackgroundPyronaridine Protects against SARS-CoV-2 Infection in Mouse
Puhl, A. C., Gomes, G. F., Damasceno, S., Godoy, A. S., Noske, G. D., Nakamura, A. M., Gawriljuk, V. O., Fernandes, R. S., Monakhova, N., Riabova, O., et al. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00091 · Cited by 32
Eyileten, C., Wicik, Z., Simões, S. N., Martins, D., Klos, K., Wlodarczyk, W., Assinger, A., Sołdacki, D., Chciałowski, A., Siller-Matula, J. M., et al. (2022) · RNA Biology · doi:10.1080/15476286.2022.2100629 · Cited by 32
“MiR155 additionally regulates pathways related with the IFN superfamily, an important regulator of inflammatory response, especially in viral infections [98,99,100].”
BackgroundPérez, S., Meyer, F., Saira, K., Doster, A. R., & Jones, C. (2008) · Journal of General Virology · doi:10.1099/vir.0.83481-0 · Cited by 30
“The viral glyco- protein gD activates interferon response factor 3 (IRF3) and consequently IFN- production in mononuclear cells (Katze et al., 2002).”
Gahlawat, S. K., Ellis, A. E., & Collet, B. (2009) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2009.02.021 · Cited by 30
p204-Initiated Innate Antiviral Response in Mouse Leydig Cells1
Zhu, W., Liu, P., Yu, L., Chen, Q., Liu, Z., Yan, K., Lee, W. M., Cheng, C. Y., & Han, D. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.114.119396 · Cited by 34
“Interferons IFNA and IFNB have important functions in the host defense against viral infection through the induction of antiviral proteins in the infected cells and the facilitation of systemic adaptive immune responses [44].”
BackgroundLi, Y., Ye, L., Peng, J., Wang, C., Luo, G. G., Zhang, T., Wan, Q., & Ho, W. (2007) · The Journal of Infectious Diseases · doi:10.1086/520093 · Cited by 30
Miyahira, Y., Katae, M., Kobayashi, S., Takeuchi, T., Fukuchi, Y., Abe, R., Okumura, K., Yagita∥, H., & Aoki, T. (2003) · Infection and Immunity · doi:10.1128/iai.71.6.3131-3137.2003 · Cited by 30
“cruzi (5, 16), the reduced secretion of IFN- during T.”
BackgroundZafeiropoulos, S., Ahmed, U., Bekiaridou, Α., Mughrabi, I. T., Mughrabi, I. T., Saleknezhad, N., Chadwick, C. M., Daytz, A. E., Kurata-Sato, I., Atisha‐Fregoso, Y., et al. (2024) · Circulation Research · doi:10.1161/circresaha.123.323679 · Cited by 30
“…, a key regulator of macrophage activation through the JAK/STAT (janus kinase/signal transducer and activator of transcription) signaling pathway, 46 and IL-10 are reduced in treated animals, findings consistent with previously reported effects of sFUS on serum IFN-γ levels and IFN-γ gene…”
ResultRecent advances in small interfering RNA sensing by the immune system
Sioud, M. (2010) · New Biotechnology · doi:10.1016/j.nbt.2010.02.015 · Cited by 32
Interferon-α Promotes the Expression of Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma
Ma, H., Jin, S., Yang, W., Tian, Z., Liu, S., Wang, Y., Zhou, G., Zhao, M., Gvetadze, S. R., Zhang, Z., et al. (2017) · Journal of Cancer · doi:10.7150/jca.19486 · Cited by 30
“In response to IFNα stimulation, STAT1 forms heterodimers with STAT2 that bind the Interferon-Stimulated Response Element (IRSE) promoter element [20].”
BackgroundInterferon-β modulates type 1 immunity during influenza virus infection
Yoo, J., Baker, D. P., & Fish, E. N. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2010.07.006 · Cited by 30
Developments towards effective treatments for Nipah and Hendra virus infection
Bossart, K. N., & Broder, C. C. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.1.43 · Cited by 29
Molecular Pathogenesis of H5N1 Influenza Virus Infections
Neumann, G., Shinya, K., & Kawaoka, Y. (2007) · Antiviral Therapy · doi:10.1177/135965350701200s08.1 · Cited by 30
Liu, G., Zhai, Q., Schaffner, D., Bradburne, C. E., Wu, A., Hayford, A. E., Popov, S. G., Grene, E., Bailey, C., & Alibek, K. (2004) · Immunology Letters · doi:10.1016/j.imlet.2003.11.015 · Cited by 32
The molecular basis of HCV-mediated immune dysregulation
Eisen-Vandervelde, A., Yao, Z. Q., & Hahn, Y. S. (2004) · Clinical Immunology · doi:10.1016/j.clim.2003.12.003 · Cited by 29
PKR-Dependent Mechanisms of Interferon-α for Inhibiting Hepatitis B Virus Replication
Park, I.-H., Baek, K.-W., Cho, E.-Y., & Ahn, B.-Y. (2011) · Molecules and Cells · doi:10.1007/s10059-011-1059-6 · Cited by 29
“IFN-α restricts viral replication by transcriptionally activating many antiviral proteins ( Katze et al., 2002 ).”
BackgroundA primer on the molecular virology of hepatitis C
Moradpour, D., & Blum, H. E. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.0965.x · Cited by 36
The role of the interferon/JAK-STAT axis in driving islet HLA-I hyperexpression in type 1 diabetes
Russell, M. A., Richardson, S. J., & Morgan, N. G. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1270325 · Cited by 29
“…intracellular viral replication products (e.g. double-stranded RNA) via endogenous pattern recognition receptors (PRR) and this will stimulate the transcription and elaboration of type I interferons (IFN) (e.g. IFN a and IFN b ) (36), or in certain circumstances type III IFN (e.g. IFN l ) (37).”
BackgroundIto, F., & Chang, A. E. (2013) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2013.06.005 · Cited by 37
Interventions for men and women with their first episode of genital herpes
Heslop, R., Roberts, H., Flower, D., & Jordan, V. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010684.pub2 · Cited by 37
Deciphering the Multifaceted Relationship between Oncolytic Viruses and Natural Killer Cells
Alvarez-Breckenridge, C. A., Yu, J., Kaur, B., Caligiuri, M. A., & Chiocca, E. A. (2011) · Advances in Virology · doi:10.1155/2012/702839 · Cited by 27
“By targeting intracellular mediators that are responsible for creating an antiviral state [89], this therapeutic approach targets the antiviral host response prior to the recruitment of antiviral cellular mediators.”
BackgroundGuo, H., Fu, X., Li, N., Lin, Q., Liu, L., & Shu-qin, W. (2016) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2016.03.003 · Cited by 28
Porcine ISG15 modulates the antiviral response during pseudorabies virus replication
Liu, H., Li, S., Yang, X., Wang, X., Li, Y., Wang, C., Chen, L., & Chang, H. (2018) · Gene · doi:10.1016/j.gene.2018.09.007 · Cited by 27
Ebrahimi, N., Aslani, S., Babaie, F., Hemmatzadeh, M., Hosseinzadeh, R., Joneidi, Z., Tourzani, Z. M., Pakravan, N., & Mohammadi, H. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107082 · Cited by 29
Zhang, R., Chen, S., Zhang, Y., Wang, M., Qin, C., Yu, C., Zhang, Y., Li, Y., Chen, L., Zhang, X., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001306 · Cited by 27
Brincks, E. L., Kucaba, T. A., Legge, K. L., & Griffith, T. S. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.07.012 · Cited by 28
“In particular, type I and type II IFN are the key cytokines produced after influenza virus infection that help activate the innate and adaptive immune responses [41].”
Thomas, S., Kolumam, G. A., & Murali‐Krishna, K. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5802 · Cited by 28
Ghosh, A. K., Majumder, M., Steele, R., RAY, R. K., & Ray, R. B. (2003) · Virology · doi:10.1016/s0042-6822(02)00029-6 · Cited by 27
Cancer immunotherapy from biology to nanomedicine
Abdelbaky, S. B., Ibrahim, M. T., Samy, H., Mohamed, M., Mohamed, H., Mustafa, M., Abdelaziz, M. M., Forrest, M. L., & Khalil, I. A. H. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.06.025 · Cited by 29
Zhou, L., Li, J., Zhou, Y., Liu, J., Zhuang, K., Gao, J., Liu, S., Sang, M., Wu, J., & Ho, W. (2015) · Molecular Human Reproduction · doi:10.1093/molehr/gav058 · Cited by 34
Palomares, R. A., Walz, H., & Brock, K. V. (2013) · Virus Research · doi:10.1016/j.virusres.2013.02.010 · Cited by 38
Yang, S., Pei, Y., & Zhao, A. (2017) · Scientific Reports · doi:10.1038/srep45922 · Cited by 27
Emerging host cell targets for hepatitis C therapy
He, Y., Duan, W., & Tan, S. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.01.009 · Cited by 27
Self-citationWang, K., Fan, X., Fan, Y., Wang, B., Han, L., & Hou, Y. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2006.00819.x · Cited by 29
Innate immune evasion by hepatitis C virus and West Nile virus
Keller, B. C., Johnson, C., Erickson, A. K., & Gale, M. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.06.006 · Cited by 28
“ISG products impart antiviral and immunomodulatory activities that limit virus replication and spread [10,11].”
BackgroundSelf-citationModulation of PKR activity in cells infected by bovine viral diarrhea virus
Gil, L. H. V. G., van Olphen, A. L., Mittal, S. K., & Donis, R. O. (2005) · Virus Research · doi:10.1016/j.virusres.2005.08.011 · Cited by 29
Interferons in Viral Infections
Sengupta, P., & Chattopadhyay, S. (2024) · Viruses · doi:10.3390/v16030451 · Cited by 27
Yaacoub, C., Wehbe, R., Roufayel, R., Fajloun, Z., & Coutard, B. (2023) · Pathogens · doi:10.3390/pathogens12111354 · Cited by 27
“…to the expression of numerous IFN-stimulated genes (ISGs) with antiviral functions, such as serine/threonine protein kinase, now recognized as PKR [54] To further understand which BV component is responsible for the antiviral or virucidal effect, the effect of MEL on the same viruses was…”
BackgroundRetroelement decay by the exonuclease XRN1 is a viral mimicry dependency in cancer
Hosseini, A., Lindholm, H. T., Chen, R. E., Mehdipour, P., Marhon, S. A., Ishak, C. A., Moore, P. C., Classon, M., Gioacchino, A. D., Greenbaum, B. D., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113684 · Cited by 32
Liu, X., Huang, J., Yang, S., Zhao, Y., Xiang, A., Cao, J., Fan, B., Wu, Z., Zhao, J., Zhao, S., et al. (2013) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2013.11.008 · Cited by 30
Mitochondrion: an emerging platform critical for host antiviral signaling
Wang, C., Liu, X., & Wei, B. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.561321 · Cited by 29
“Co-evolutionarily, microbes encode mechanisms to counteract the host response and support efficient microbial invasion [4,5].”
BackgroundSamsonov, A., Zenser, N., Zhang, F., Zhang, H., Fetter, J. R., & Malkov, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068391 · Cited by 26
“In response to either IFN-α or IFN-β stimulation, STAT1 forms a heterodimer with STAT2 that can bind the ISRE (Interferon Stimulated Response Element) promoter element [17].”
BackgroundFactors Affecting the Tissue Damaging Consequences of Viral Infections
Sumbria, D., Berber, E., & Rouse, B. T. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02314 · Cited by 28
Gupta, S., Ylä‐Anttila, P., Sandalova, T., Achour, A., & Masucci, M. G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00437 · Cited by 25
Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits
Banerjee, A., Ganguly, U., Saha, S., Chakrabarti, S., Saini, R. V., Rawal, R. K., Saso, L., & Chakrabarti, S. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1905519 · Cited by 28
“enhance the expressions of multiple genes such as type I interferons (IFNs), IFN-stimulated genes, and genes for cytokines and chemokines [39].”
BackgroundManipulation of dendritic cell functions by human cytomegalovirus
Sinclair, J. H. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000872 · Cited by 26
Interferon-alpha Induces High Expression of APOBEC3G and STAT-1 in Vitro and in Vivo
Chen, H., Wang, L.-W., Huang, Y., & Gong, Z. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11093501 · Cited by 29
“The expression products of ISGs are many kinds of antiviral proteins including dsRNA-activated protein kinase (PKR), GBP-2, MxA, RANTES, and 2-5' oligoadenylate synthetase (OAS) [12], which are able to inhibit viral replication at the levels of penetration, uncoating, mRNA synthesis, protein synthesis, or assembly [1…”
BackgroundFrøkiær, H., Henningsen, L., Metzdorff, S. B., Weiss, G., Roller, M., Flanagan, J., Fromentin, E., & Ibarra, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047878 · Cited by 26
“In addition to its strong antiviral effects and regulation of innate and adaptive immunity [4], IFN-b has anti-inflammatory properties, upregulating IL-1b receptor antagonist [5], which mitigates the proinflammatory effects of IL-1b [6].”
BackgroundT-regulatory lymphocytes and chronic viral hepatitis
Rushbrook, S., Hoare, M., & Alexander, G. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.11.1689 · Cited by 27
“However, recent data from both in vivo and in vitro models suggests that the process is more sophisticated, so that antigen recognition via the CD8 + T-cell receptor (TCR) can activate CD8 + T cells to secrete antiviral cytokines (such as IFNγ or TNFα ) leading to inhibition of viral entry, uncoating and viral replica…”
BackgroundBrockmeier, S. L., Loving, C. L., Eberle, K. C., Hau, S. J., Buckley, A., Geelen, A. V., Montiel, N. A., Nicholson, T. L., & Lager, K. M. (2017) · Veterinary Microbiology · doi:10.1016/j.vetmic.2017.11.004 · Cited by 26
Viruses with deletions in antiapoptotic genes as potential oncolytic agents
Liu, T., & Kirn, D. H. (2005) · Oncogene · doi:10.1038/sj.onc.1208734 · Cited by 33
“On the other hand, HSV g 34.5 recruits cellular protein phosphatase 1a (PP1a) to dephosphorylate eukaryotic initiation factor 2, a-subunit (eIF-2a), which is downstream of PKR (Katze et al., 2002).”
BackgroundInfluentialActivation and Inhibition of Virus and Interferon: The Herpesvirus Story
Mossman, K. L. (2002) · Viral Immunology · doi:10.1089/088282402317340198 · Cited by 27
Kiyotani, K., Sakaguchi, T., Kato, A., Nagai, Y., & Yoshida, T. (2006) · Virology · doi:10.1016/j.virol.2006.08.053 · Cited by 26
Feline herpesvirus-1: Ocular manifestations, diagnosis and treatment options
Gould, D. J. (2012) · Cited by 25
Viral infections and chronic rhinosinusitis
Volpe, S., Irish, J. D., Palumbo, S., Lee, E., Herbert, J. R., Ramadan, I., & Chang, E. H. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.07.018 · Cited by 27
Innate Antiviral Defenses Independent of Inducible IFNα/β Production
Paludan, S. R. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.06.003 · Cited by 29
Interferon Independent Non-Canonical STAT Activation and Virus Induced Inflammation
Nan, Y., Wu, C., & Zhang, Y. (2018) · Viruses · doi:10.3390/v10040196 · Cited by 27
“Subsequent cascade events after the triggering of the pathway result in expression of IFN-stimulated genes (ISGs) [14].”
BackgroundNanotechnology synergized immunoengineering for cancer
Chauhan, D. S., Dhasmana, A., Laskar, P., Prasad, R., Jain, N. K., Srivastava, R., Jaggi, M., Chauhan, S. C., & Yallapu, M. M. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.03.010 · Cited by 28
Role of non-coding RNAs in Dengue virus-host interaction
Madhry, D., Pandey, K. K., Kaur, J., Rawat, Y., Sapra, L., Ravi Kumar, Y. S., Srivastava, R. K., Bhattacharyya, S., & Verma, B. (2021) · Frontiers in Bioscience-Scholar · doi:10.52586/s552 · Cited by 25
“…phosphorylation of translation factor eIF2a by PKR, causing global translational arrest finally leading to apoptosis of the infected cells [ 40–43]. miRNAs or siRNAs generated as a result of antiviral immune response can also stimulate helicase RIG-1/MDA5 pathway which is suggestive that…”
BackgroundDNA Damage Response Signaling Is Crucial for Effective Chikungunya Virus Replication
Chatterjee, S., Kumar, S., Mamidi, P., Datey, A., Sengupta, S., Mahish, C., Laha, E., De, S., Keshry, S. S., Nayak, T. K., et al. (2022) · Journal of Virology · doi:10.1128/jvi.01334-22 · Cited by 23
“CHIKV-infected cell supernatants, as it was shown in previous study that type I interferons can suppress viral infection (30).”
Cytokine-induced tumor suppressors: A GRIM story
Kalvakolanu, D. V., Nallar, S. C., & Kalakonda, S. (2010) · Cytokine · doi:10.1016/j.cyto.2010.03.009 · Cited by 25
Gerberding, J. L., Morgan, J. G., Shepard, J.-A. O., & Kradin, R. L. (2004) · New England Journal of Medicine · doi:10.1056/nejmcpc049006 · Cited by 26
Vijayan, M., Xia, C., Song, Y. E., Ngo, H., Studstill, C. J., Drews, K., Fox, T. E., Johnson, M. C., Hiscott, J. B., KESTER, M. A., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601959 · Cited by 28
“type I IFN signaling pathway to a certain extent (4, 12, 13).”
BackgroundCharacterization of internal ribosomal entry sites of Triatoma virus
Czibener, C., Alvarez, D. D., Scodeller, E. A., & Gamarnik, A. V. (2005) · Journal of General Virology · doi:10.1099/vir.0.80842-0 · Cited by 25
“…whether the IRES activities present in the TrV genome were differentially modulated by an ‘antiviral state’ of the cell, we analysed the translation efficiency of the two IRESs in BHK cells pre-treated with IFN-a, which is known to induce phosphorylation of IF2-a (reviewed by Katze et al., 2002).”
Konopka, J. L., Thompson, J. M., Whitmore, A. C., Webb, D. L., & Johnston, R. E. (2009) · Journal of Virology · doi:10.1128/jvi.00564-09 · Cited by 26
“The action of IFN-induced genes can be quite virus specific, and a particular gene product or combination of responses may be required for complete protection (38, 59, 62).”
BackgroundCoughlin, J. E., Pandey, R. K., Padmanabhan, S., O’Loughlin, K. G., Marquis, J. K., Green, C. E., Mirsalis, J. C., & Iyer, R. P. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.044446 · Cited by 25
“…et al., 2010) that certain SMNH analogs can activate cellular cytosolic pathogen recognition receptors such as retinoic acid-inducible gene (RIG-I) (Katze et al., 2002; Akira et al., 2006; Saito et al., 2007; Myong et al., 2009) and nucleotide oligomerization domain protein 2 (Sabbah et al., 2009;…”
BackgroundAnalysis of a bovine herpesvirus 1 recombinant virus that does not express the bICP0 protein
Geiser, V., Zhang, Y., & Jones, C. (2005) · Journal of General Virology · doi:10.1099/vir.0.80921-0 · Cited by 26
“5 and US11 inhibit the IFN response and do not grow efficiently (Katze et al., 2002; Mossman & Smiley, 2002; Mossman et al., 2000, 2001).”
InfluentialCD30-targeted oncolytic viruses as novel therapeutic approach against classical Hodgkin lymphoma
Hanauer, J. D. S., Rengstl, B., Kleinlützum, D., Reul, J., Pfeiffer, A., Friedel, T., Schneider, I. C., Newrzela, S., Hansmann, M., Buchholz, C. J., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24191 · Cited by 24
“In healthy cells, including T lymphocytes, however, viral infection induces antiviral mechanisms of the innate immune system for example the expression of type-I interferons [23].”
BackgroundHerpes Simplex Virus 1 ICP34.5 Alters Mitochondrial Dynamics in Neurons
Manivanh, R. V., Mehrbach, J., Charron, A. J., Grassetti, A. V., Cerón, S., Taylor, S. A., Cabrera, J. R., Gerber, S. A., & Leib, D. A. (2020) · Journal of Virology · doi:10.1128/jvi.01784-19 · Cited by 23
Mokhtari, R. B., Sambi, M., Qorri, B., Baluch, N., Ashayeri, N., Kumar, S., Cheng, H. M., Yeger, H., Das, B., & Szewczuk, M. R. (2021) · Cancers · doi:10.3390/cancers13143596 · Cited by 27
Haghighi-Najafabadi, N., Roohvand, F., Nosrati, M. S. S., Teimoori‐Toolabi, L., & Azadmanesh, K. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.105164 · Cited by 25
Herpes Virus MicroRNA Expression and Significance in Serous Ovarian Cancer
Pandya, D. S., Mariani, M., McHugh, M., Andreoli, M., Sieber, S. C., He, S., Martino, C., Fiedler, P. N., Scambia, G., & Ferlini, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114750 · Cited by 26
“Viral dsRNA is a potent trigger of the interferon response which phosphorylates the translation factor eIF2a and leads to global translational arrest and apoptosis [6, 7, 8].”
BackgroundGaajetaan, G. R., Geelen, T. H., Grauls, G., Bruggeman, C. A., & Stassen, F. R. M. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.10.015 · Cited by 26
“These cytokines are normally the first antiviral mediators produced in mice during viral infection (Baig and Fish, 2008; Katze et al., 2002).”
BackgroundCloning, expression and immunoassay detection of ferret IFN-γ
Ochi, A., Danesh, A., Seneviratne, C., Banner, D., DeVries, M. E., Rowe, T., Xu, L., Ran, L., Czub, M., Bosinger, S. E., et al. (2008) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2007.12.008 · Cited by 27
“IFN-g is also necessary for T cell-mediated viral clearance and limitation of latent viral infections [21] .”
BackgroundLinks between Human LINE-1 Retrotransposons and Hepatitis Virus-Related Hepatocellular Carcinoma
Honda, T. (2016) · Frontiers in Chemistry · doi:10.3389/fchem.2016.00021 · Cited by 24
“Type I interferons (IFNs) play a major role in anti-viral immunity (Katze et al., 2002).”
BackgroundHao, Z., Fu, F., Cao, L., Guo, L., Liu, J., Xue, M., & Feng, L. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.02.005 · Cited by 26
“Many aspects of the viral life cycle can be mediated through a variety of cellular defense mechanisms (Katze et al., 2002).”
BackgroundSeo, Y., Alexander, S., & Hahm, B. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.12.001 · Cited by 27
“Viruses often block the production or signaling of type I IFN to evade host innate immune responses [43–47].”
BackgroundCreery, D., WEISS, W., Lim, W., Aziz, Z., Angel, J. B., & Kumar, A. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02495.x · Cited by 28
Deficiency in Either 4E-BP1 or 4E-BP2 Augments Innate Antiviral Immune Responses
Nehdi, A., Sean, P., Linares, I., Colina, R., Jaramillo, M., & Alain, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114854 · Cited by 23
Metadata
- Authors
- Katze, M. G., He, Y., & Gale, M.
- Affiliations
- University of Washington (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Katze, Michael G.
- Venue
- Nature Reviews Immunology
- Published
- 2002-09-01
- Volume
- 2
- Issue
- 9
- Pages
- 675-687
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2079295092
- Cited by
- 1,419
- References
- 138
- Citations by year
- 2026: 30 · 2025: 62 · 2024: 89 · 2023: 82 · 2022: 67 · 2021: 48 · 2020: 35 · 2019: 30 · 2018: 23 · 2017: 38 · 2016: 41 · 2015: 40 · 2014: 55 · 2013: 58 · 2012: 55
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- interferon, antiviral immunity, host-virus interaction, interferon-stimulated genes, viral evasion of host defense, influenza virus, hepatitis C virus, herpes simplex virus, vaccinia virus, antiviral drug targets
- MeSH terms
- Animals, Hepatitis C, Herpes Simplex, Humans, Interferon Type I, Membrane Glycoproteins, Orthomyxoviridae, Orthomyxoviridae Infections, Receptors, Cell Surface, Vaccinia, Vaccinia virus, Virus Diseases, Virus Replication, Hepacivirus, Simplexvirus, Computational Biology, Databases as Topic, Genomics, Drosophila Proteins, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.